• Diabetes Drug Reduces Acute GVHD After Stem Cell Transplant

    9 days ago - By Medscape

    Adding the diabetes drug sitaliptin to immunosuppression therapies for patients undergoing stem cell transplant reduced the risk of developing acute graft-vs-host disease .
    Medscape Medical News
    Read more ...


  • Hope for children with rare heart condition: novel stem cell therapy to save the day

    9 days ago - By ScienceDaily

    Researchers put forward a safe and efficient new stem cell therapy for regenerating cardiac function in pediatric patients.
    Read more ...